Manuscripts

Search by keyword, year, or author name.

Showing 1543 manuscripts.

Comparison of two serum HIV antigen assays for selection of asymptomatic antigenemic individuals into clinical trials

Brooks Jackson, Kim Sannerud, Henry H. Balfour. Comparison of two serum HIV antigen assays for selection of asymptomatic antigenemic individuals into clinical trials. Journal of Acquired Immune Deficiency Syndromes. 1989. 2: 394-7.

Year

1989

Journal

Journal of Acquired Immune Deficiency Syndromes

Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs

Brooks Jackson, Shirley Y. Kwok, J. S. Hopsicker, Kim Sannerud, John Sninsky, J. R. Edson, Henry H. Balfour. Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs. TRANSFUSION. 1989. 29: 265-7.

Year

1989

Journal

TRANSFUSION

Results of the flow cytometry ACTG quality control program: analysis and findings

Helene M.A. Paxton, Pamela Gill Kidd, Alan Landay, Janis V. Giorgi, Neal Flomenberg, Edwin B. Walker, Fred T. Valentine, John L. Fahey, Rebecca S. Gelman. Results of the flow cytometry ACTG quality control program: analysis and findings. Clinical Immunology and Immunopathology (Now Clin Immunol). 1989. 52: 68-84.

Year

1989

Journal

Clinical Immunology and Immunopathology (Now Clin Immunol)

Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro

Richard S. Kornbluth, Philip S. Oh, James R. Munis, Patrick H. Cleveland, Douglas D. Richman. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. Journal of Experimental Medicine. 1989. 169: 1137-51.

Year

1989

Journal

Journal of Experimental Medicine

Probenecid and zidovudine metabolism

David Kornhauser, Brent Gray Petty, Craig Hendrix, Amina S. Woods, Lynda Nerhood, John G. Bartlett, Paul S. Lietman. Probenecid and zidovudine metabolism. Lancet. 1989. 2: 473-5.

Year

1989

Journal

Lancet

Why high levels of virus-specific CTL persist in HIV1-infected individuals

Richard A. Koup, John L. Sullivan. Why high levels of virus-specific CTL persist in HIV1-infected individuals. Research In Immunology. 1989. 140: 92-5.

Year

1989

Journal

Research In Immunology

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

Brendan Larder, G. Darby, Douglas D. Richman. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 1989. 243: 1731-4.

Year

1989

Journal

Science

Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR

David M Markovitz, Shannon Kenney, J. Kamine, Marilyn S. Smith, Marilyn Davis, E. Huang, C. Rosen, Joseph S. Pagano. Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR. Virology. 1989. 173: 750-4.

Year

1989

Journal

Virology

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections: a phase I and II study

Thomas C. Merigan, Gail Skowron, Sam Bozzette, Douglas D. Richman, Raj B. Uttamchandani, Margaret A. Fischl, Robert T. Schooley, Martin S. Hirsch, Whaijen Soo, Carla Pettinelli, Herbert H. Schaumburg. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections: a phase I and II study. Annals of Internal Medicine. 1989. 110: 189-94.

Year

1989

Journal

Annals of Internal Medicine

Measurement of human immunodeficiency virus load and its relation to disease progression

Lee Ratner. Measurement of human immunodeficiency virus load and its relation to disease progression. AIDS Research and Human Retroviruses. 1989. 5: 115-9.

Year

1989

Journal

AIDS Research and Human Retroviruses